Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Apr 05, 2021 9:56pm
187 Views
Post# 32939599

RE:RE:RE:RE:RE:RE:RE:Start of Photofrin trial delayed

RE:RE:RE:RE:RE:RE:RE:Start of Photofrin trial delayed
99942Apophis wrote: Perhaps they are aware of Theralase's partnership with St. Michaels Hospital and the Li Ka Shing Institute. Could be Roswell might be throwing the towel in on NSCLC and move onto something else, my opinion " they don't stand a chance of coming close".


I think that TLT's move to 'hook up' with LKSKI put some pressure on RPCC. Maybe they know(suspect?) 1433 is the better one to use with their fancy lung device? Maybe they want to seriously do a head to head? then decide early which one to go with? Maybe they have a serious interest in 1433 and want to know if it works before they miss out? That special lung treatment device they now have controlling interest in could be the way to treat the NSCLC. If they have the correct compound. Those who know about 1433 are starting to jockey position... Maybe...

<< Previous
Bullboard Posts
Next >>